RAD-502

N/A

Report date: 2025/09/10 14:02:47

Base Information

Drug NameRAD-502

Drug Alias NameRAD-502177Lu-RAD-502

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsOsteosarcoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesRadiopharm Theranostics Ltd

China Registration ClassN/A

Develop Information

Active CompaniesRadiopharm Theranostics Ltd

Inactive CompaniesN/A

Active IndicationsOsteosarcoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A